CRISPR technology: A versatile tool to model, screen, and reverse drug resistance in cancer

CRISPR technology: A versatile tool to model, screen, and reverse drug resistance in cancer

Background: Drug resistance is a serious challenge in cancer treatment that can render chemotherapy a failure. Understanding the mechanisms behind drug resistance and developing novel therapeutic approaches are cardinal steps in overcoming this issue. Clustered regularly interspaced short palindrome...

Full description

Bibliographic Details
Main Authors:	Shiva Shirani-Bidabadi, Aliye Tabatabaee, Nazita Tavazohi, Amirali Hariri, Amir Reza Aref, Ali Zarrabi, Nicolette Casarcia, Anupam Bishayee, Mina Mirian
Format:	Article
Language:	English
Published:	Elsevier 2023-06-01
Series:	European Journal of Cell Biology
Subjects:	Cancer Drug resistance CRISPR technology Cancer therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S0171933523000146

Similar Items

Protocol for in vivo CRISPR screening using selective CRISPR antigen removal lentiviral vectors
by: Sarah Kate Lane-Reticker, et al.
Published: (2023-03-01)

Generation of gene-of-interest knockouts in murine organoids using CRISPR-Cas9
by: Anne Huber, et al.
Published: (2023-03-01)

CRISPR-Cas and CRISPR-based screening system for precise gene editing and targeted cancer therapy
by: Mingming Qin, et al.
Published: (2024-05-01)

Protocol for genomic editing in human resting primary NK cells and NK-92 cells via CRISPR-Cas9 ribonucleoproteins
by: Tias Verhezen, et al.
Published: (2024-09-01)

A Review: CRISPR Cas System and the Mechanism With an Inhibition of Binding of CRISPR Cas‐9
by: Akram Hosen, et al.
Published: (2025-01-01)

Knowledge mapping and current trends of global research on CRISPR in the field of cancer
by: Han Liu, et al.
Published: (2023-05-01)

Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges
by: Bashdar Mahmud Hussen, et al.
Published: (2023-07-01)

The CRISPR revolution and its impact on cancer research
by: Ram Kannan, et al.
Published: (2015-11-01)

Phytochemicals regulate cancer metabolism through modulation of the AMPK/PGC-1α signaling pathway
by: Sajad Fakhri, et al.
Published: (2024-09-01)

CRISPR/Cas9, a new approach to successful knockdown of ABCB1/P-glycoprotein and reversal of chemosensitivity in human epithelial ovarian cancer cell line
by: Leyla Norouzi-Barough, et al.
Published: (2018-02-01)

Engineered extracellular vesicles mediated CRISPR-induced deficiency of IQGAP1/FOXM1 reverses sorafenib resistance in HCC by suppressing cancer stem cells
by: Cong He, et al.
Published: (2023-05-01)

Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR tools
by: Martina Celotti, et al.
Published: (2024-09-01)

Oncogenic Human Papillomavirus: Application of CRISPR/Cas9 Therapeutic Strategies for Cervical Cancer
by: Shuai Zhen, et al.
Published: (2017-12-01)

Revitalizing oral cancer research: Crispr-Cas9 technology the promise of genetic editing
by: Sowmya S. V., et al.
Published: (2024-06-01)

Advances in CRISPR-Cas technology and its applications: revolutionising precision medicine
by: Sarkar Sardar Azeez, et al.
Published: (2024-12-01)

Protocol for CRISPR-Cas9-mediated induction of KMT2A rearrangements in cell line and umbilical cord blood hematopoietic stem and progenitor cells
by: Tamara Benz, et al.
Published: (2025-03-01)

A CRISPR Test for Rapidly and Sensitively Detecting Circulating EGFR Mutations
by: Jen-Hui Tsou, et al.
Published: (2020-02-01)

Engineering CRISPR/Cas9 therapeutics for cancer precision medicine
by: Aditya Kumar Sharma, et al.
Published: (2024-04-01)

Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction
by: Ali A. Rabaan, et al.
Published: (2023-02-01)

CRISPR/Cas9 nanoeditor of double knockout large fragments of E6 and E7 oncogenes for reversing drugs resistance in cervical cancer
by: Xianhuang Li, et al.
Published: (2021-08-01)

Molecular Mechanisms of Breast Cancer Drug Resistance and CRISPR/Cas9 Strategies to Overcome
by: Bashdar Mahmud Hussen, et al.
Published: (2024-12-01)

GMP-manufactured CRISPR/Cas9 technology as an advantageous tool to support cancer immunotherapy
by: M Caforio, et al.
Published: (2024-03-01)

Research Progress on Nanoparticles-Based CRISPR/Cas9 System for Targeted Therapy of Tumors
by: Dengyun Nie, et al.
Published: (2022-09-01)

Protocol for generation and engineering of thyroid cell lineages using CRISPR-Cas9 editing to recapitulate thyroid cancer histotype progression
by: Vincenzo Davide Pantina, et al.
Published: (2024-09-01)

“Pass the Genetic Scalpel”: A Comprehensive Review of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) in Urological Cancers
by: Arthur Yim, et al.
Published: (2024-02-01)

Applications of CRISPR screening to lung cancer treatment
by: Wanying Shen, et al.
Published: (2023-12-01)

Protocol for IPO11 deletion and re-expression in H460 lung cancer cells using CRISPR-Cas9 and plasmid transfection
by: Yarui Zhang, et al.
Published: (2023-06-01)

Revealing Temozolomide Resistance Mechanisms via Genome-Wide CRISPR Libraries
by: Clarissa Ribeiro Reily Rocha, et al.
Published: (2020-12-01)

Targeting Telomeres and Telomerase: Studies in Aging and Disease Utilizing CRISPR/Cas9 Technology
by: Andrew C. Brane, et al.
Published: (2019-02-01)

Application and Prospect of CRISPR/Cas9 Technology in Reversing Drug Resistance of Non-Small Cell Lung Cancer
by: Lu Huang, et al.
Published: (2022-05-01)

CRISPR, CAR-T, and NK: Current applications and future perspectives
by: Mohadeseh Khoshandam, et al.
Published: (2024-07-01)

Optimization of CRISPR–Cas system for clinical cancer therapy
by: Xiang Meng, et al.
Published: (2023-03-01)

Editorial: CRISPR advancement in cancer research and future perspectives
by: Alessio Biagioni, et al.
Published: (2023-03-01)

Targeting the MALAT1 gene with the CRISPR/Cas9 technique in prostate cancer
by: Soraya Ahmadi-Balootaki, et al.
Published: (2022-09-01)

Synthetically modified guide RNA and donor DNA are a versatile platform for CRISPR-Cas9 engineering
by: Kunwoo Lee, et al.
Published: (2017-05-01)

A benchmark of algorithms for the analysis of pooled CRISPR screens
by: Sunil Bodapati, et al.
Published: (2020-03-01)

Genome editing approaches with CRISPR/Cas9: the association of NOX4 expression in breast cancer patients and effectiveness evaluation of different strategies of CRISPR/Cas9 to knockout Nox4 in cancer cells
by: Marzieh Javadi, et al.
Published: (2023-11-01)

Recruitment of Reverse Transcriptase-Cas1 Fusion Proteins by Type VI-A CRISPR-Cas Systems
by: Nicolás Toro, et al.
Published: (2019-09-01)

CRISPR/Cas9: Transcending the Reality of Genome Editing
by: Sergiu Chira, et al.
Published: (2017-06-01)

Genetic engineering in oncology based on CRISPR-Cas9 technology
by: D. Sh. Polatova, et al.
Published: (2024-09-01)